1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with HbS Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, X; Anstee, D; Chasis, JA; Kaul, DK; Liu, XD; Mankelow, T; Mohandas, N; Parsons, S; Spring, F; Zhang, X | 1 |
Barabino, GA; Chang, HY; Finnegan, EM; Jonczyk, A; Kaul, DK; Liu, XD | 1 |
Ibe, BO; Johnson, C; Kurantsin-Mills, J; Oh, SO; Raj, JU | 1 |
Coller, BS; Kaul, DK; Liu, XD; Nagel, RL; Nakada, MT; Tsai, HM | 1 |
Kaul, DK; Liu, X; Nagel, RL | 1 |
Haynes, J; Obiako, B | 1 |
Brugnara, C; Jarolim, P; Rivera, A | 1 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and HbS Disease
Article | Year |
---|---|
Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation.
Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Cell Adhesion Molecules; Endothelial Cells; Erythrocytes, Abnormal; Humans; In Vitro Techniques; Integrin alphaV; Microcirculation; Peptides; Platelet Activating Factor; Protein Binding; Protein Structure, Tertiary; Protein Transport; Rats; Regression Analysis | 2006 |
Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.
Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Cells, Cultured; Endothelial Cells; Erythrocytes; Humans; Integrin alphaVbeta3; Microcirculation; Peptides, Cyclic; Platelet Activating Factor; Rats; Splanchnic Circulation; Vascular Patency; Vascular Resistance | 2007 |
Platelet-activating factor in plasma of patients with sickle cell disease in steady state.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aging; Anemia, Sickle Cell; Blood Platelets; Body Weight; Female; Hemoglobins; Humans; Male; Phospholipases A; Platelet Activating Factor; Platelet Count | 1997 |
Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.
Topics: Abciximab; Adult; Anemia, Sickle Cell; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cecum; Cell Adhesion; Endothelium, Vascular; Erythrocytes; Humans; Immunoglobulin Fab Fragments; Platelet Activating Factor; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Receptors, Vitronectin; Reference Values; Venules | 2000 |
Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature.
Topics: Adult; Anemia, Sickle Cell; Animals; Cecum; Cell Adhesion; Drug Carriers; Drug Evaluation, Preclinical; Emulsions; Endothelium, Vascular; Erythrocytes, Abnormal; Fluorocarbons; Humans; Hydrocarbons, Brominated; Microcirculation; Oxygen; Perfusion; Platelet Activating Factor; Rats; Solubility; Vascular Resistance | 2001 |
Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids.
Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Chromium Radioisotopes; Erythrocytes; Humans; In Vitro Techniques; Leukotriene B4; Male; NADPH Oxidases; Neutrophils; Perfusion; Phospholipids; Platelet Activating Factor; Positive-Pressure Respiration; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Tidal Volume | 2002 |
Modulation of Gardos channel activity by cytokines in sickle erythrocytes.
Topics: Anemia, Sickle Cell; Calcium; Cell Size; Chemokine CCL5; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Erythrocyte Count; Erythrocytes, Abnormal; Humans; Interleukin-10; Kinetics; Oligopeptides; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Potassium Channels, Calcium-Activated; Protein Kinase C; Receptor, Endothelin B; Receptors, CCR5; Receptors, Cell Surface; Receptors, Chemokine; Receptors, Endothelin; Receptors, G-Protein-Coupled; Rubidium Radioisotopes | 2002 |